Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
07/2011
07/13/2011EP2342196A1 Pyrazole compounds for controlling invertebrate pests
07/13/2011EP2342195A2 Crystalline forms of a 3-pyrrole substituted 2-indolinone malate salt
07/13/2011EP2342194A1 Oxoazetidine derivatives, process for the preparation thereof and use thereof in human medicine and in cosmetics
07/13/2011EP2342191A1 Aromatic nitrogen-containing 6-membered ring compounds and their use
07/13/2011EP2342190A1 Bicyclic kinase inhibitors
07/13/2011EP2342183A1 1,3 imidazolidine derivatives and their use in the production of carbapenem
07/13/2011EP2342182A1 Isoquinolinone derivatives as nk3 antagonists
07/13/2011EP2342178A1 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
07/13/2011EP2341775A1 Inhibitors of janus kinases
07/13/2011EP1539717B1 Microbiocidal (e.g fungicidal) 1,2,3-triazole derivatives
07/13/2011CN1989104B Cyclic amide derivatives, and their production and use as antithrombotic agents.
07/13/2011CN1915990B Method for preparingLosartan
07/13/2011CN1903846B Ornidazole derivative used for therapy, its preparation method and use
07/13/2011CN1902193B Quinoxalines useful as inhibitors of protein kinases
07/13/2011CN1867562B Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
07/13/2011CN102124589A Phosphorescent light-emitting composition and light-emitting element comprising the composition
07/13/2011CN102124002A Novel phenylimidazole derivatives as pde10a enzyme inhibitors
07/13/2011CN102123998A Isoquinolinone derivatives as nk3 antagonists
07/13/2011CN102123991A 2 -arylaminoquinazolines for treating proliferative diseases
07/13/2011CN102123710A Bicyclic triazole derivatives for treating tumors
07/13/2011CN102121209A Preparation method of polysulfate diphenyl ethylene fluorescent whitening agent
07/12/2011US7977482 Dark coloured azo dyes
07/12/2011US7977480 Synthesis of paliperidone
07/12/2011US7977371 Pyrrole derivative having ureido group and aminocarbonyl group as substituents
07/12/2011US7977340 Antibacterial compositions
07/12/2011US7977336 Aminopyrimidine derivatives as PLK1 inhibitors
07/12/2011US7977334 N-(3-{2-[3-(6-amino-benzimidazol-1-yl)-1,1-dimethyl-propylamino]-1-hydroxy-ethyl}-phenyl)-benzenesulphonamide; beta(3)-Adrenoceptor agonists; antidiabetic, obesity modulator, insulin resistance
07/12/2011US7977333 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
07/12/2011US7977329 Obesity therapy; using 3-benzoazepine compound
07/12/2011CA2669128C Treatment for multiple myeloma
07/12/2011CA2517629C Phthalazinone derivatives
07/12/2011CA2503451C Heterocyclic compounds and antitumor agent comprising the same as effective component
07/12/2011CA2500113C Therapeutic piperazine compounds
07/12/2011CA2422617C Tripeptidyl peptidase inhibitors
07/07/2011WO2011082267A2 Substituted triazolo-pyrazine compounds
07/07/2011WO2011082266A2 Substituted heterocyclic compounds
07/07/2011WO2011082077A1 Hepatitis c virus inhibitors
07/07/2011WO2011081408A2 Imatinib dichloroacetate and anti-cancer agent comprising the same
07/07/2011WO2011080751A2 α4β2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
07/07/2011WO2011080718A1 Inhibitors of diacylglycerol acyl transferase
07/07/2011WO2011080684A1 Process for the preparation of candesartan cilexetil
07/07/2011WO2011080445A1 Novel (heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors
07/07/2011WO2011080176A1 Pyrazine derivatives and their use in the treatment of neurological disorders
07/07/2011WO2011080043A1 Ureidopyrimidones; cosmetic use as uv-screening agents; antisun compositions containing them
07/07/2011WO2011079969A1 A 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative for pharmaceutical use, and the use of a 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative with substantially undefined crystal shape for preparing said 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative
07/07/2011WO2011058521A3 Process for the preparation of crystalline form i of l-malic acid salt of sunitinib
07/07/2011WO2011054783A3 Processes for the preparation of 5 - lipooxygenase activating protein inhibitors and their intermediates
07/07/2011WO2010125382A3 New process and new compounds
07/07/2011US20110166364 Synthesis of 3--5-[2-(phenylsulfonyl)ethyl]-1h-indole
07/07/2011US20110166343 Thienopyrazole derivative having pde7 inhibitory activity
07/07/2011US20110166169 Novel hsp90 inhibitory carbazole derivatives, compositions containing same and use thereof
07/07/2011US20110166168 Sulphone-substituted quinazoline derivatives as immuno-modulators, their preparation and use as medicaments
07/07/2011US20110166159 Compounds that modulate intracellular calcium
07/07/2011US20110166158 Substituted phenylamine carboxamide analogs as mglur5 negative allosteric modulators and methods of making and using the same
07/07/2011US20110166155 Substituted Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators
07/07/2011US20110166142 2-substituted isoflavonoid compounds, medicaments and uses
07/07/2011US20110166140 Novel sulphonylpyrroles
07/07/2011US20110166138 Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase for Modulation of Cannabinoid Receptors
07/07/2011US20110166137 Substituted Naphthalenyl-Pyrimidine Compounds
07/07/2011US20110166136 Calcium Ion Channel Modulators & Uses Thereof
07/07/2011US20110166132 Gamma Secretase Modulators
07/07/2011US20110166128 Diaryldiazepine Prodrugs for the Treatment of Neurological and Psychological Disorders
07/07/2011US20110166117 Novel Compounds
07/07/2011US20110166116 New compounds, pharmaceutical composition and methods relating thereto
07/07/2011US20110166102 Novel 2-substituted benzimidazoles as selective androgen receptor modulators (sarms)
07/07/2011US20110166096 Uracil derivatives and use thereof
07/07/2011US20110165118 3-heterocyclic substituted indole derivatives and methods of use thereof
07/07/2011US20110165087 Targeted delivery of imaging probes for in vivo cellular imaging
07/07/2011CA2788450A1 Substituted naphthalenyl-pyrimidine compounds
07/07/2011CA2785957A1 .alpha.4.beta.2 neuronal nicotinic acetylcholine receptor ligands
07/07/2011CA2785341A1 Pyrazine derivatives and their use in the treatment of neurological disorders
07/07/2011CA2784153A1 Novel (heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors
07/06/2011EP2341064A1 Benzimidazole compounds and their use as chromatographic ligands
07/06/2011EP2340836A1 Co-crystals comprising VX-950 and their pharmaceutical compositions
07/06/2011EP2340830A2 Hepatitis C Virus Inhibitors
07/06/2011EP2340248A2 Methods and compositions for modulating ire1, src, and abl activity
07/06/2011EP2340243A1 Heteroaryl substituted indole compounds useful as mmp-13 inhibitors
07/06/2011EP2340021A1 Substituted pyrrolidine-2-carboxamides
07/06/2011EP2339919A1 Bicyclic dihydroimidazolone cgrp receptor antagonists
07/06/2011EP2152370B1 Aryl ether pyridazinone derivatives
07/06/2011EP2010519B1 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators
07/06/2011EP1611108B1 Method for the production of telmisartan
07/06/2011CN1709870B Optical-purity N',N'-dibasic prolyl hydrazine compound, and its preparing method and use
07/06/2011CN102119158A Novel nitrogen-containing heterocyclic compound and organic electronic device using the same
07/06/2011CN102119157A Tricyclic 2,4-diamino-L,3,5-triazine derivatives useful for the treatment of cancer and myeloproliferative disorders
07/06/2011CN102119047A Heteroaryl derivatives as DGAT1 inhibitors
07/06/2011CN102115470A Pyrimidine small-molecular compounds, and preparation method and application thereof
07/06/2011CN102115460A Geldanamycin derivative and preparation method and application thereof
07/06/2011CN101341136B Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same
07/05/2011US7973170 N3 alkylated benzimidazole derivatives as MEK inhibitors
07/05/2011US7973161 N-acylsulfonamide derivatives; BCL-X1 protein inhibitors; anticarcinogenic agents; bladder cancer; for example, N-(4-(4-((4'-chloro(1,1'-biphenyl)-2-yl)methyl)piperazin-1-yl)benzoyl)-4-(((1R)-3-(dimethylamino)-1-((phenylsulfanyl)methyl)-propyl)amino)-3-nitrobenzenesulfonamide
07/05/2011US7973044 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
07/05/2011US7973041 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
07/05/2011CA2564563C Indolyl derivatives as liver-x-receptor modulators
07/05/2011CA2517571C Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
07/05/2011CA2483228C Carboxamides
07/05/2011CA2476583C Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
07/05/2011CA2459172C Bicyclic compound, production and use thereof
07/05/2011CA2423279C Phthalazinone derivatives
06/2011
06/30/2011WO2011079327A1 Analogues for the treatment or prevention of flavivirus infections